HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Atria Investments Inc

Atria Investments Inc cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 19.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 9,031 shares of the company’s stock after selling 2,190 shares during the period. Atria Investments Inc’s holdings in HealthEquity were worth $739,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. grew its position in HealthEquity by 1.7% during the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock valued at $715,783,000 after acquiring an additional 149,133 shares during the period. Vaughan Nelson Investment Management L.P. grew its holdings in shares of HealthEquity by 1.8% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 616,860 shares of the company’s stock worth $53,173,000 after purchasing an additional 11,150 shares during the period. Oppenheimer Asset Management Inc. increased its position in HealthEquity by 29.4% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company’s stock worth $5,535,000 after purchasing an additional 14,573 shares in the last quarter. Diversify Wealth Management LLC purchased a new position in HealthEquity in the second quarter valued at approximately $8,182,000. Finally, Sequoia Financial Advisors LLC acquired a new position in HealthEquity during the second quarter valued at approximately $1,122,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 10,536 shares of company stock valued at $884,517 in the last quarter. Insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

HQY has been the topic of several recent research reports. BTIG Research lifted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Royal Bank of Canada restated an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. JMP Securities reiterated a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Friday. They set a “neutral” rating and a $108.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $107.23.

HealthEquity Trading Up 3.5 %

HQY opened at $102.40 on Tuesday. HealthEquity, Inc. has a 12-month low of $62.10 and a 12-month high of $103.12. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The stock has a market capitalization of $8.94 billion, a PE ratio of 85.33, a P/E/G ratio of 1.55 and a beta of 0.52. The firm’s fifty day moving average price is $85.54 and its 200 day moving average price is $81.25.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. The business had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, research analysts expect that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.